A selective Fibroblast Growth Factor Receptor 1/2 PROTAC degrader with antitumor activity.
Kong Y, Zhao X, Wang Z, Yuan S, Chen S, Lou S, Ma S, Li Y, Wang X, Ge Y, Li G, Yang H, Zhao M, Li D, Zhang H, Tan W, Wang J.
Kong Y, et al. Among authors: ma s.
Mol Cancer Ther. 2024 Apr 22. doi: 10.1158/1535-7163.MCT-23-0719. Online ahead of print.
Mol Cancer Ther. 2024.
PMID: 38647531